Billon have created a technology that enables zero cost global payments by the use of a simple mobile app. Billon's mobile app allows you to instantly pay for the rest of an article from the Guardian or even donate to your favourite Youtubers with a few clicks of a button.
days to go:
Expired
investment:
£1,406,667
Publisher Discovery, using AI & Machine Learning technologies, provides recommendations to Advertisers of highly relevant Publishers in the affiliate marketing sector. The company has built a uniquely curated database of over 2 million publishers and 330,000 advertisers, which are then analysed, compared, and matched to make recommendations in ranked lists, matching the best publishers with each advertiser. The affiliate publishing market is worth 16 billion dollars per year but is still largely dominated by human-based agencies and is uniquely suited for automation. Publisher Discovery aims to capitalise on this aspect and establish itself as the market leader. The company has signed up over 50 publishers and is negotiating contracts with two large distribution partners. It is currently raising £1 million investment with £675,000 committed so far, to grow sales and operations and reach over £2m Annual Recurring Revenue (ARR) in the following 12 months.
days to go:
Expired
investment:
£800,000
epaysecure is a secure payment system, which offers comprehensive payment and benefit options, and allows all the services the consumer demands to be offered in one card and e-account. The prepaid business purchasing in European markets is estimated to be $700 million. The company operates in an e-banking and financial services marketing sector that helps clients by identifying new markets and bringing in new ideas to develop them through reloadable products and e-Wallet platform. The funds will be used for staffing, set up costs, other overheads including property marketing and general office costs.
days to go:
Expired
investment:
£168,340
Founded by entrepreneurs, Oliver Hutley (COO) and Rory Chichester (CEO), TECS Group is an expert provider of technology. TECS Group delivers non-discretionary critical services, such as Electrical Testing and Treatment, Gas Safety, and Fire Safety, on behalf of customers. These services are covered by strict legislation & regulation. Following a constant period of investment into developing a scalable and a solid operating platform, the TECS Group is embarking on its subsequent stage of growth. With the proceeds, the company will deliver and successfully implement its technology strategy, successfully drive for organic sales, increase the national coverage, and continue its final program.
days to go:
Expired
investment:
£96,770
The Face Recognition Company (FRC) produces 90%+ accurate face recognition solution. In 2016, the company came up with the objective to develop the most accurate and cost-effective facial recognition solution. This technology is suitable for commercial applications or crime and other security uses. Additionally, the FRC's go-to-market strategy incorporates working through large integrators/partners/approved installers, eight of which are ready to promote and install its product to their own customer base. The FRC team has technically developed this solution by combining 100 years of experience in facial recognition. In June 2018, FRC had filed for two patents: first, ‘Recognition of 3D Objects’ and second, 'Method of and System for Recognising a Human Face’. Where suitable, FRC has also set-up an EIS tax relief.
days to go:
Expired
investment:
£215,600
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go:
Expired
investment:
Withheld
Zone V makes the latest tablets and smartphones work for the older generation with low eyesight, deficient hearing or dexterity. The company has redefined a global platform that is providing access to the services that are difficult to use. They have a technological partnership with Samsung and are a Samsung Managed Solutions Partner. The company also creates inclusively accessible technology, services, and applications for more smoother and viable communication. The executive team of this company includes health, telecoms, and wellness fields. With the proceeds, Zone V will widen the digital divide for the older smartphones users by working tirelessly to build new innovative communication solutions.
days to go:
Expired
investment:
£500,000
Doc2UK is a specialist UK medical recruitment and candidate support platform. Based in London, the platform places qualified doctors in the National Health Scheme (NHS) roles around the United Kingdom. The British Medical Association (2018) reported that patient care is at risk due to a critical shortage of doctors across multiple medical disciplines. At present, the UK only has 24 medical schools to fill this gap, whilst India, in comparison, has 468 medical schools, with 68,000 doctors graduating each year. Moreover, uncertainty about the status of EU nationals after Brexit, changes to immigration policies, and the impact of changing language testing requirements for international nurses have made this crisis worse. This situation necessitates recruiting doctors from overseas an important endeavour. This is where Doc2UK aims to become a key player and ensure that lack of medical personnel doesn't disrupt any medical services. The company is seeking an investment of up to £300,000 which will be used to develop the platform with more features, expand the team, marketing and sales.
days to go:
Expired
investment:
Withheld
An IT recruitment and training site launched to meet the demands of enterprises that require highly skilled tech professionals. 365 Talent Portal offers companies to hire IT consultants at a lower price compared to traditional recruitment hubs. The company also allows IT professionals registered on the site to access training and certification programmes that will expand their current skillset and become more marketable to potential employers.
365 Talent Portal is raising funds to produce more prominent marketing campaigns and establish their brand in major markets such as the USA. In addition to this, the company will be using AI more heavily and develop a more automated approach on their platform for their customers.
days to go:
Expired
investment:
£156,000
3DUserNet is an online portal for viewing and collaborating on 3D data projects. Its SaaS platform enables team members in engineering and construction companies to store, view, navigate and collaborate online, through any modern browser or device, without the need for installed software. The company has been working with sectors such as surveying, policing, civil engineering, security, road safety, and defence. Since its inception, it has added multiple measurement tools including clip boxes, line of sight, checkpoint tool, and slope tool on its platform. The company is seeking an investment of up to £400,000, at a pre-money valuation of £1.6 million under which it is offering investors making up the first £200,000 a discounted share price of £3.4733. Investors joining in for the remaining £200,000 thereafter will purchase a share for £4.6622. The funds raised will be used for further platform development, sales and marketing, and working capital.
days to go:
Expired
investment:
Withheld
